Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: SC 13D/A, Date: 2016-02-02
Original SEC Filing: Click here

---

Webplus: SVA/20160202/SC_13D.A/2_EX-7.01/000.htm SEC Original: v430210_ex7-01.htm
Joint Filing Agreement This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument. [Remainder of this page has been left intentionally blank.] SAIF Partners IV L.P. Andrew Y. Yan Director of SAIF IV GP Capital Ltd., which is the General Partner of SAIF IV GP, L.P., which is

---

---

Webplus: SVA/20160202/SC_13D.A/3_EX-7.02/000.htm SEC Original: v430210_ex7-02.htm
January 30, 2016 The Board of Directors Sinovac Biotech Ltd. No. 39 Shangdi Xi Road, Haidian District, Beijing 100085 People’s Republic of China Dear Members of the Board of Directors Company Buyer Group Proposal Transaction 2 We believe that our Proposal provides a very attractive opportunity to the Company’s shareholders. Our Proposal represents a premium of approximately 23.11% to the

---

---

Webplus: SVA/20160202/SC_13D.A/1/000.htm SEC Original: v430210_sc13da.htm

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: SC 13D/A, Date: 2016-02-02CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085